Cart
sales@molnova.com
AZ-1355
CAS No. 75451-07-9
AZ-1355( —— )
Catalog No. M33202 CAS No. 75451-07-9
AZ-1355 is a novel dibenzoxepine derivative with lipid-lowering properties.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 159 | In Stock |
|
| 5MG | 174 | In Stock |
|
| 10MG | 236 | In Stock |
|
| 25MG | 356 | In Stock |
|
| 50MG | 476 | In Stock |
|
| 100MG | 620 | In Stock |
|
| 200MG | 846 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAZ-1355
-
NoteResearch use only, not for human use.
-
Brief DescriptionAZ-1355 is a novel dibenzoxepine derivative with lipid-lowering properties.
-
DescriptionAZ-1355 is an effctive lipid-lowering compound, which also inhibits platelet aggregation in vivo and elevates the prostaglandin I2/thromboxane A2 ratio in vitro.
-
In Vitro——
-
In VivoAZ-1355 (50 mg/kg) significantly reduces serum TG and the 100 mg/kg dose results in serum TC and TG reduction in rat. AZ-1355 (100 mg/kg) reduces total liver TC in rats fed CE-2, and the 50 mg/kg dose reduces hepatic TC in rats fed the high fat diet on both bases, and it also reduces the total hepatic TG of the CE-2 fed rats. AZ-1355 (150 mg/kg) reproducibly lowers serum total cholesterol (TC) in the Triton hyperlipidemic mice.
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetProstaglandin Receptor
-
RecptorProstaglandin Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number75451-07-9
-
Formula Weight299.32
-
Molecular FormulaC17H17NO4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO(C)C1=C2C(CNC=3C(O2)=CC=C(C(OCC)=O)C3)=CC=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wada S, et al. The lipid-lowering profile in rodents. AZ-1355, a new dibenzoxazepine derivative. Atherosclerosis. 1981 Nov-Dec;40(3-4):263-71.?
molnova catalog
related products
-
ASP7657
ASP7657 (ASP-7657) is a potent, selective, orally active prostaglandin EP4 receptor antagonist with Ki values of 6.02 nM and 2.21 nM for rat and human EP4 receptors, resepctively.
-
BMY 45778
A potent, non-prostanoid prostacyclin partial agonist that potently inhibits human (IC50=35 nM), rabbit (IC50=136 nM) and rat (IC50=1.3 uM) platelet aggregation.
-
Aligeron
Aligeron, a non-selective prostaglandin (PG) antagonist, inhibits PGF2α- and PGE2-induced blood pressure decreases in cats and can prevent PGF2α-induced diarrhea in mice and PGE2-induced paw edema in rats.
